View in EDS HTML Full Text PDF Full Text

Ten Years of Experience With Buprenorphine in a Private Psychiatric Outpatient Practice.

Saved in:
Bibliographic Details
Title: Ten Years of Experience With Buprenorphine in a Private Psychiatric Outpatient Practice.
Authors: Feder, Robert (AUTHOR)
Source: American Journal on Addictions. Nov2020, Vol. 29 Issue 6, p508-514. 7p. 3 Charts, 1 Graph.
Subjects: Opioid abuse, Buprenorphine, Substance-induced disorders, Physician-patient relations, Autism spectrum disorders, Psychiatric practice, Substance abuse & psychology, Substance abuse, Narcotic antagonists, Outpatient medical care, Retrospective studies, Treatment effectiveness, Medical practice, Longitudinal method
Abstract: Background and Objectives: There have been few reports of buprenorphine treatment of opioid use disorder in private psychiatric practice. This report describes such a patient population and the outcomes obtained.Methods: Chart reviews were performed on 285 patients seen over a 10-year period in the author's solo private psychiatric practice. Quantitative and qualitative data were reviewed and analyzed.Results: Comorbidity of psychiatric disorders was high (75%), while comorbidity of substance use disorders was low (5%, alcohol only). Fourteen percent of patients completed treatment (tapered off of buprenorphine and remained opioid-free for up to 7 years). Forty-eight percent of the sample had good outcomes (remaining on buprenorphine and abstinent of other opioids), 28% had poor outcomes, and 10% dropped out of prolonged successful treatment with unknown final outcomes. The group achieved a relatively high rate of smoking cessation during the study (22%). There were high rates of language disorder (21.6%) and autism spectrum disorder (8.6%) in children of mothers in the study.Discussion and Conclusion: Outcomes were excellent compared with those reported in other treatment settings. Rates of smoking cessation were also notable. The treatment of comorbid psychiatric conditions, the setting to develop a strong physician-patient relationship, patients choosing whether to taper off of buprenorphine, and the slow rate of taper all likely contributed to successful outcomes. Further investigation is needed regarding possible increased rates of developmental disorders in children of mothers treated with buprenorphine.Scientific Significance: Private psychiatric practice is a highly successful domain for the treatment of opioid use disorder. (Am J Addict 2020;29:508-514). [ABSTRACT FROM AUTHOR]
Copyright of American Journal on Addictions is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 146927238
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ten Years of Experience With Buprenorphine in a Private Psychiatric Outpatient Practice.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Feder%2C+Robert%22">Feder, Robert</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22American+Journal+on+Addictions%22">American Journal on Addictions</searchLink>. Nov2020, Vol. 29 Issue 6, p508-514. 7p. 3 Charts, 1 Graph.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Opioid+abuse%22">Opioid abuse</searchLink><br /><searchLink fieldCode="DE" term="%22Buprenorphine%22">Buprenorphine</searchLink><br /><searchLink fieldCode="DE" term="%22Substance-induced+disorders%22">Substance-induced disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Physician-patient+relations%22">Physician-patient relations</searchLink><br /><searchLink fieldCode="DE" term="%22Autism+spectrum+disorders%22">Autism spectrum disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Psychiatric+practice%22">Psychiatric practice</searchLink><br /><searchLink fieldCode="DE" term="%22Substance+abuse+%26+psychology%22">Substance abuse & psychology</searchLink><br /><searchLink fieldCode="DE" term="%22Substance+abuse%22">Substance abuse</searchLink><br /><searchLink fieldCode="DE" term="%22Narcotic+antagonists%22">Narcotic antagonists</searchLink><br /><searchLink fieldCode="DE" term="%22Outpatient+medical+care%22">Outpatient medical care</searchLink><br /><searchLink fieldCode="DE" term="%22Retrospective+studies%22">Retrospective studies</searchLink><br /><searchLink fieldCode="DE" term="%22Treatment+effectiveness%22">Treatment effectiveness</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+practice%22">Medical practice</searchLink><br /><searchLink fieldCode="DE" term="%22Longitudinal+method%22">Longitudinal method</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: <bold>Background and Objectives: </bold>There have been few reports of buprenorphine treatment of opioid use disorder in private psychiatric practice. This report describes such a patient population and the outcomes obtained.<bold>Methods: </bold>Chart reviews were performed on 285 patients seen over a 10-year period in the author's solo private psychiatric practice. Quantitative and qualitative data were reviewed and analyzed.<bold>Results: </bold>Comorbidity of psychiatric disorders was high (75%), while comorbidity of substance use disorders was low (5%, alcohol only). Fourteen percent of patients completed treatment (tapered off of buprenorphine and remained opioid-free for up to 7 years). Forty-eight percent of the sample had good outcomes (remaining on buprenorphine and abstinent of other opioids), 28% had poor outcomes, and 10% dropped out of prolonged successful treatment with unknown final outcomes. The group achieved a relatively high rate of smoking cessation during the study (22%). There were high rates of language disorder (21.6%) and autism spectrum disorder (8.6%) in children of mothers in the study.<bold>Discussion and Conclusion: </bold>Outcomes were excellent compared with those reported in other treatment settings. Rates of smoking cessation were also notable. The treatment of comorbid psychiatric conditions, the setting to develop a strong physician-patient relationship, patients choosing whether to taper off of buprenorphine, and the slow rate of taper all likely contributed to successful outcomes. Further investigation is needed regarding possible increased rates of developmental disorders in children of mothers treated with buprenorphine.<bold>Scientific Significance: </bold>Private psychiatric practice is a highly successful domain for the treatment of opioid use disorder. (Am J Addict 2020;29:508-514). [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of American Journal on Addictions is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=146927238
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/ajad.13060
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 508
    Subjects:
      – SubjectFull: Opioid abuse
        Type: general
      – SubjectFull: Buprenorphine
        Type: general
      – SubjectFull: Substance-induced disorders
        Type: general
      – SubjectFull: Physician-patient relations
        Type: general
      – SubjectFull: Autism spectrum disorders
        Type: general
      – SubjectFull: Psychiatric practice
        Type: general
      – SubjectFull: Substance abuse & psychology
        Type: general
      – SubjectFull: Substance abuse
        Type: general
      – SubjectFull: Narcotic antagonists
        Type: general
      – SubjectFull: Outpatient medical care
        Type: general
      – SubjectFull: Retrospective studies
        Type: general
      – SubjectFull: Treatment effectiveness
        Type: general
      – SubjectFull: Medical practice
        Type: general
      – SubjectFull: Longitudinal method
        Type: general
    Titles:
      – TitleFull: Ten Years of Experience With Buprenorphine in a Private Psychiatric Outpatient Practice.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Feder, Robert
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 10550496
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: American Journal on Addictions
              Type: main
ResultId 1